Ireland recommends suspending AstraZeneca jab over blood clot fears

"The National Immunisation Advisory Committee (NIAC) has recommended that the administration of COVID-19 Vaccine AstraZeneca be temporarily deferred from this morning," Ireland's deputy chief medical officer Ronan Glynn said in a statement.

AFP
He said the recommendation has been made "on the precautionary principal" after "a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination".
Ireland's vaccine taskforce on Sunday recommended temporarily suspending the rollout of the AstraZeneca coronavirus jab, following reports of blood clots in adults who received the shot.

"The National Immunisation Advisory Committee (NIAC) has recommended that the administration of COVID-19 Vaccine AstraZeneca be temporarily deferred from this morning," Ireland's deputy chief medical officer Ronan Glynn said in a statement.

He said the recommendation has been made "on the precautionary principal" after "a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination".

Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › News › International › World News › Ireland recommends suspending AstraZeneca jab over blood clot fears
Text Size:AAA
Success
This article has been saved

*

+